Ignite Creation Date:
2025-12-24 @ 12:01 PM
Ignite Modification Date:
2026-07-06 @ 9:12 AM
Study NCT ID:
NCT00724061
Status:
TERMINATED
Last Update Posted:
2018-12-12
First Post:
2008-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL
Sponsor:
Northwestern University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Lymphoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent mycosis fungoides/Sezary syndrome | View |
| None | stage I mycosis fungoides/Sezary syndrome | View |
| None | stage II mycosis fungoides/Sezary syndrome | View |
| None | stage III mycosis fungoides/Sezary syndrome | View |
| None | stage IV mycosis fungoides/Sezary syndrome | View |
| None | recurrent cutaneous T-cell non-Hodgkin lymphoma | View |
| None | stage I cutaneous T-cell non-Hodgkin lymphoma | View |
| None | stage II cutaneous T-cell non-Hodgkin lymphoma | View |
| None | stage III cutaneous T-cell non-Hodgkin lymphoma | View |
| None | stage IV cutaneous T-cell non-Hodgkin lymphoma | View |